期刊文献+

慢性心力衰竭患者系统化干预对心功能状况和再住院率的影响 被引量:4

The impact of systematic management on the cardiac function and readmission rate in patients with chronic heart failure
原文传递
导出
摘要 目的 探讨系统化院外干预对慢性心力衰竭(CHF)患者心功能及再住院率的影响.方法 入选2008年7月至2010年7月中国医科大学北京顺义医院心内科住院CHF患者160例,按随机数字表法分为干预组79例,对照组81例.干预组患者根据心功能的变化和临床症状进行系统化干预,包括规范治疗方案,指导患者正确使用血管紧张素转换酶抑制剂和β-受体阻滞剂,并滴定其靶剂量等措施.对照组不做系统化干预,了解记录自用药情况和其他相关内容.6个月和12个月时分别对两组患者采用6分钟步行试验及超声心动图检查对患者的心功能状况进行评价,使用再住院率对患者临床症状改善进行评价.结果 6、12个月时干预组6分钟步行距离[(345.27±123.95)、(368.94±121.62) m]明显高于对照组[(282.53±94.63)、(260.07±86.13) m],差异有统计学意义(F组间=38.01,P<0.01;F组内=19.62,P<0.01;F交互=48.36,P<0.01).干预组的左心室射血分数[6个月(43.48±8.42)%,12个月(41.21±6.23)%]明显高于对照组[(37.70±7.13)%、(37.15±6.83)%](P<0.01).6个月时干预组再住院率有下降趋势,12个月时干预组再住院次数(26次)明显低于对照组(36次),差异有统计学意义(P =0.024).结论 CHF患者采用系统化干预可以改善其心功能并降低再住院率. Objective To explore the impact of systematic management on the cardiac function and readmission rate in patients with chronic heart failure(CHF).Methods One hundred and sixty CHF patients in Beijing Shunyi Hospital Affiliated to China Medical University from Jul.2008 to Jul.2010 were selected as our subjects and random divided into intervention (79 cases) and control group(81 cases).Patients in intervention group were received systematic therapy based on heart function and clinical syndrome including therapy plan and guiding the application of angiotensin converting enzyme inhibitor and beta blockers,and in control group were received regular therapy.The cardiac function were evaluated by 6-minute walking test (6MWT) and echocardiography,and readmission rate was observed.Results (1)The result of 6MWT in the intervention group at 6 months and 12 months were (345.27 ± 123.95) m,(368.94 ± 121.62) m,significantly higher than that of 6MWT in the control group ((282.53 ± 94.63) m,(260.07 ± 86.13) m; F between groups =38.01,P 〈0.01 ;F inner group =19.26,P 〈 0.01 ; F across group =48.36,P 〈 0.01).(2) Left ventricular ejection fraction in the intervention group at 6 months and 12 months were (43.48 ± 8.42) %,(41.21 ± 6.23) %,significantly higher than that in the control group ((37.70 ±7.13)%,(37.15 ±6.83)% ;P 〈0.001).(3)The readmission rate in the intervention group showed a decreased trend but did not reach statistically significant difference at 6 months,while the readmission times in the intervention group at 12 months was 26,significantly lower than that in the control group (36,P =0.024).Conclusion The systematic management might improve the heart function and reduce readmission rates in patients with CHF.
出处 《中国综合临床》 2014年第9期911-913,共3页 Clinical Medicine of China
基金 首都医学发展科研基金资助项目(2007-3184)
关键词 慢性心力衰竭 系统化干预 心功能 再住院率 Chronic heart failure Systematic management Cardiac function Readmission rate
  • 相关文献

参考文献9

二级参考文献65

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2Cleland JG, Clark A. Has the survival of the heart failure population changed? Lessons from trials. Am J Cardiol, 1999,83:112D-119D.
  • 3Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J, 1997,133:703-712.
  • 4Gary R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA, 1995,273:1450-1456.
  • 5Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet, 1998,352:19-28.
  • 6Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure: a request for more accurate classification. Eur Heart J, 1996,17:1390-1403.
  • 7Pierpont GL, Cohn JN, Franciosa JA. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest, 1978,73:8-13.
  • 8Jugdutt BI, Khan MI. Effect of prolonged nitrate therapy on left ventricular remodeling after canine myocardial infarction. Circulation, 1994,89:2297-2307.
  • 9Packer M, O′Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in servere chronic heart failure. N Engl J Med, 1996,335:1107-1114.
  • 10Cohn JN, Ziesche S, Smith R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-Heft III. Circulation, 1997,96:856-863.

共引文献3946

同被引文献29

  • 1郑莜萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.286.
  • 2Drewes HW,Steuten LM,Lemmens LC,et al.The effectiveness of chronic care management for heart failure:meta-regression analyses to explain the heterogeneity in outcomes[J].Health Serv Res,2012,47(5):1926-59.
  • 3Fragasso G,Rosano G, Baek SH, et al. Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an internationai muhicentre retrospective cohort study [J] .Int J Cardiol, 2013,163(3) :320-325.
  • 4Gao D, Ning N, Niu X, et al. Trimetazidine : a meta-analysis of randomised controlled trials in heart failure [J]. Heart, 2011,97 (4) :278-286.
  • 5Zhang L, Lu Y, Jiang H, et al. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis [J] .J Am Coll Cardiol,2012,59 (10) :913-922.
  • 6Grajek S, Michalak M. The effect of trimetazidine added to pharmacological treatment on all-cause mortality in patients with systolic heart failure [J]. Cardiology, 2015, 131 ( 1 ) : 22-29.
  • 7Florkowski CM, Molyneux SL, Young JM. Coenzyme Q10 and congestive heart failure; an evolving evidence base [J]. Kardiol Pol,2015,73(2) :73-79.
  • 8Sander S,Coleman CI, Patel AA, et al. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure [J]. J Card Fail,2006,12(6) :464-472.
  • 9Fotino AD,Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis [J] .Am J Clin Nutr, 2013,97 (2) : 268-275.
  • 10MortensenSA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure [J]. J Am Coil Cardiol Heart Failure, 2014, 2(6) : 641 - 649.

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部